Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Using Benefit-Risk Profile of Existing Cancer Drugs to Determine Optimal Regimen and New Formulations with David Young Processa Pharmaceuticals TRANSCRIPT

Download PDF

Nov 21, 2023

David Young, President of R&D at Processa Pharmaceuticals, talks about the FDA's Project Optimus draft guidance on optimal dosage regimens for specific patients. Processa is modifying existing cancer-killing molecules to improve efficacy and decrease side effects by taking into account genetic factors and the...

Read More

Using Benefit-Risk Profile of Existing Cancer Drugs to Determine Optimal Regimen and New Formulations with David Young Processa Pharmaceuticals

Nov 21, 2023

David Young, President of R&D at Processa Pharmaceuticals, talks about the FDA's Project Optimus draft guidance on optimal dosage regimens for specific patients. Processa is modifying existing cancer-killing molecules to improve efficacy and decrease side effects by taking into account genetic factors and the...

Read More

Developing Phosphatase Inhibitors to Treat Rare Neurodevelopmental Disorder with Andreas Grill DepYmed TRANSCRIPT

Download PDF

Nov 20, 2023

Andreas Grill, President and CEO of DepYmed, discusses protein tyrosine phosphatase-targeted drugs, a new class of drugs. With a focus on the specific enzyme PTP1B, DepYmed discovered orally bioavailable molecules that inhibit PTP1B, targeting the signal transaction pathway. They are initially testing to treat...

Read More

Developing Phosphatase Inhibitors to Treat Rare Neurodevelopmental Disorder with Andreas Grill DepYmed

Nov 20, 2023

Andreas Grill, President and CEO of DepYmed, discusses protein tyrosine phosphatase-targeted drugs, a new class of drugs. With a focus on the specific enzyme PTP1B, DepYmed discovered orally bioavailable molecules that inhibit PTP1B, targeting the signal transaction pathway. They are initially testing to treat...

Read More

Providing Specialty Pharmacy Care to High-Risk Patients with Brian Smith Shields Health Solutions TRANSCRIPT

Download PDF

Nov 13, 2023

Brian Smith, Chief Pharmacy Officer at Shields Health Solutions, addresses the challenges patients experience receiving specialty drugs by working with health systems to simplify the process. With a focus on measuring outcomes and improving patient care, Shields has seen a significant cure rate for hepatitis C, driven...

Read More